Genedrive
Victoria Chapman is a seasoned professional in assay development and research, currently serving as an Assay Development Manager at genedrive plc since September 2021. Previously, Victoria worked as a Research Scientist at Epistem Ltd. from January 2016 to June 2018 and conducted their doctoral research at the University of Manchester from September 2011 to September 2015, focusing on the effects of chemical allergy on the mouse lymph node DNA methylome. Earlier experience includes a role as a Product Development Scientist at QIAGEN, where responsibilities encompassed real-time and reverse transcription PCR assay design. Victoria holds a Bachelor of Science degree in Biology from the University of Manchester, completed in 2009.
Genedrive
The Genedrive® molecular diagnostic system has been developed as an affordable next generation genotyping and sequence analysis device, providing rapid detection in approximately 45-75 minutes depending on the test.